BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26111246)

  • 1. The clinical application of plasma Kaposi sarcoma herpesvirus viral load as a tumour biomarker: results from 704 patients.
    Haq IU; Dalla Pria A; Papanastasopoulos P; Stegmann K; Bradshaw D; Nelson M; Bower M
    HIV Med; 2016 Jan; 17(1):56-61. PubMed ID: 26111246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can plasma HHV8 viral load be used to differentiate multicentric Castleman disease from Kaposi sarcoma?
    Sayer R; Paul J; Tuke PW; Hargreaves S; Noursadeghi M; Tedder RS; Grant P; Edwards SG; Miller RF
    Int J STD AIDS; 2011 Oct; 22(10):585-9. PubMed ID: 21998180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.
    Marcelin AG; Motol J; Guihot A; Caumes E; Viard JP; Dussaix E; Cadranel J; Frances C; Carcelain G; Calvez V; Dupin N
    J Infect Dis; 2007 Oct; 196(8):1163-6. PubMed ID: 17955434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
    Min J; Katzenstein DA
    AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservation of virally encoded microRNAs in Kaposi sarcoma--associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease.
    Marshall V; Parks T; Bagni R; Wang CD; Samols MA; Hu J; Wyvil KM; Aleman K; Little RF; Yarchoan R; Renne R; Whitby D
    J Infect Dis; 2007 Mar; 195(5):645-59. PubMed ID: 17262705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
    Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
    Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and survival for HIV-associated multicentric Castleman disease in Malawi.
    Gopal S; Liomba NG; Montgomery ND; Moses A; Kaimila B; Nyasosela R; Chikasema M; Dhungel BM; Kampani C; Sanders MK; Krysiak R; Dittmer DP; Fedoriw Y
    J Int AIDS Soc; 2015; 18(1):20122. PubMed ID: 26242311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.
    Carbone A; De Paoli P; Gloghini A; Vaccher E
    Int J Cancer; 2015 Jul; 137(2):251-61. PubMed ID: 24771491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.
    Uldrick TS; Wang V; O'Mahony D; Aleman K; Wyvill KM; Marshall V; Steinberg SM; Pittaluga S; Maric I; Whitby D; Tosato G; Little RF; Yarchoan R
    Clin Infect Dis; 2010 Aug; 51(3):350-8. PubMed ID: 20583924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of human herpesvirus 8 by real-time PCR in blood fractions of AIDS patients with Kaposi's sarcoma and multicentric Castleman's disease.
    Boivin G; Côté S; Cloutier N; Abed Y; Maguigad M; Routy JP
    J Med Virol; 2002 Nov; 68(3):399-403. PubMed ID: 12226828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
    Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
    AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) DNA Viral Load in Whole Blood for Diagnosis and Monitoring of KSHV-Associated Diseases.
    Jary A; Leducq V; Palich R; Gothland A; Descamps D; Joly V; Lambert-Niclot S; Amiel C; Canestri A; Mirand A; Gault E; Vabret A; Valantin MA; Katlama C; Calvez V; Dupin N; Spano JP; Marcelin AG
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29643199
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
    Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
    J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
    Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
    Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma.
    Deloose ST; Smit LA; Pals FT; Kersten MJ; van Noesel CJ; Pals ST
    Leukemia; 2005 May; 19(5):851-5. PubMed ID: 15744337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of Kaposi sarcoma (KS)-associated herpesvirus viremia and KS disease in Zimbabwe.
    Campbell TB; Borok M; White IE; Gudza I; Ndemera B; Taziwa A; Weinberg A; Gwanzura L
    Clin Infect Dis; 2003 May; 36(9):1144-51. PubMed ID: 12715309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
    Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
    J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Kaposi's sarcoma associated herpesvirus (KSHV) DNA in bronchoalveolar lavage fluid of HIV infected individuals with bronchoscopically diagnosed tracheobronchial Kaposi's sarcoma.
    Howard MR; Brink NS; Whitby D; Tedder RS; Miller RF
    Sex Transm Infect; 1998 Feb; 74(1):27-31. PubMed ID: 9634297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis.
    Lidenge SJ; Tso FY; Ngalamika O; Ngowi JR; Mortazavi Y; Kwon EH; Shea DM; Minhas V; Mwaiselage J; Wood C; West JT
    J Infect Dis; 2019 Apr; 219(8):1318-1328. PubMed ID: 30452681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of Kaposi sarcoma-associated herpesvirus (KSHV) in KSHV-associated diseases.
    Asahi-Ozaki Y; Sato Y; Kanno T; Sata T; Katano H
    J Infect Dis; 2006 Mar; 193(6):773-82. PubMed ID: 16479510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.